An economic evaluation of atenolol vs. captopril in patients with Type 2 diabetes (UKPDS 54).
about
Blood pressure control for diabetic retinopathyExamining the economic costs related to lifestyle and pharmacological interventions in youth with Type 2 diabetes.Cost-effectiveness of oral hypoglycaemic agents for the treatment of type 2 diabetes mellitus.Spoilt for choice: implications of using alternative methods of costing hospital episode statistics.
P2860
An economic evaluation of atenolol vs. captopril in patients with Type 2 diabetes (UKPDS 54).
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
An economic evaluation of aten ...... th Type 2 diabetes (UKPDS 54).
@en
An economic evaluation of atenolol vs. captopril in patients with Type 2 diabetes
@nl
type
label
An economic evaluation of aten ...... th Type 2 diabetes (UKPDS 54).
@en
An economic evaluation of atenolol vs. captopril in patients with Type 2 diabetes
@nl
prefLabel
An economic evaluation of aten ...... th Type 2 diabetes (UKPDS 54).
@en
An economic evaluation of atenolol vs. captopril in patients with Type 2 diabetes
@nl
P2093
P2860
P1433
P1476
An economic evaluation of aten ...... th Type 2 diabetes (UKPDS 54).
@en
P2093
I Stratton
UKPDS Group
P2860
P304
P356
10.1046/J.1464-5491.2001.00485.X
P577
2001-06-01T00:00:00Z